21 results found.

Crohn Disease, or Ulcerative Colitis Clinical Trial using VSL#3

Charles University, Czech Republic - Recruiting N/A or older.
- The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease.
VSL#3

Crohn's Disease, Inflammatory Bowel Disease, IBD, or Colitis Clinical Trial using Group 3: ustekinumab approximately 6 mg/kg; Group 1: Placebo; Group 2 ustekinumab 130 mg

Janssen Research & Development, LLC - Recruiting 18 years or older.
- A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects With Moderately to Severely Active Crohn's Disease (UNITI-2).
Group 3: ustekinumab approximately 6 mg/kg; Group 1: Placebo; Group 2 ustekinumab 130 mg

Inflammatory Bowel Disease, Crohn's Disease, or Ulcerative Coliti Clinical Trial using Infliximab, adalimumab, certolizumab pegol

Oslo University Hospital - Recruiting 18 years or older.
- Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease.
Infliximab, adalimumab, certolizumab pegol

Chronic Granulomatous Disease (CGD), Atherosclerosis, Immune Defi Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System.

Crohn's Disease, Inflammatory Bowel Disease, or Ulcerative Coliti Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 8 years to 75 years.
- Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut.

Inflammatory Bowel Diseases, Crohn's Disease, Gastrointestinal Di Clinical Trial using Mesalazine, Tripterygium glycosides

Jinling Hospital, China - Recruiting 18 years to 75 years.
- Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission.
Mesalazine, Tripterygium glycosides

Ulcerative Colitis Clinical Trial using tofacitinib; Placebo

Pfizer - Recruiting 18 years or older.
- A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.
tofacitinib; Placebo

Ulcerative Colitis Clinical Trial using Placebo; CP690,550

Pfizer - Recruiting 18 years or older.
- A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis.
Placebo; CP690,550

Inflammatory Bowel Disease, Endoscopy, or Sedation Clinical Trial using Propofol; Midazolam; Fentanyl

Copenhagen University Hospital at Herlev - Recruiting 18 years to 90 years.
- Nurse Administered Propofol Sedation vs. Standard Therapy for Colonoscopy in Patients With IBD. A Randomised Controlled Study on Satisfaction and Adherence to Treatment Program..
Propofol; Midazolam; Fentanyl

Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, or In Clinical Trial using Anti TNF therapy including infliximab; No Biologics

Janssen Biotech, Inc. - Recruiting 1 Month to 17 years.
- A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease.
Anti TNF therapy including infliximab; No Biologics

Crohn's Diseases, Inflammatory Bowel Disease, or Gut Bacteria Clinical Trial using FMT; 5-ASA, Prednisone, Azathioprine or Remicade

The Second Hospital of Nanjing Medical University - Recruiting 14 years to 70 years.
- Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Crohn's Diseases in Ileum and Colon.
FMT; 5-ASA, Prednisone, Azathioprine or Remicade

Inflammatory Bowel Diseases Clinical Trial using Infliximab; Adalimumab

Erasmus Medical Center - Recruiting 6 years or older.
- Biomarkers Predicting the Effect of Anti-TNF Treatment in Pediatric and Adult Inflammatory Bowel Disease.
Infliximab; Adalimumab

Inflammatory Bowel Disease Clinical Trial

Connecticut Children's Medical Center - Recruiting 1 Month to 16 years.
- Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry.

Crohn's Disease Clinical Trial using Fecal Microbial Transplantation

Beth Israel Deaconess Medical Center - Recruiting 18 years or older.
- .
Fecal Microbial Transplantation

Crohn's Disease, Ulcerative Colitis, Clostridium Difficile, or In Clinical Trial using Blood and stool sample

Boston Medical Center - Recruiting 18 years or older.
- Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients.
Blood and stool sample

Inflammatory Bowel Disease Clinical Trial

McMaster University - Recruiting 19 years to 85 years.
- Investigating Serotonin Signalling in IBD Patients.

Crohn's Disease, Ulcerative Colitis, or Inflammatory Bowel Diseas Clinical Trial

Medical College of Wisconsin - Recruiting N/A to 18 years.
- Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease.

Iron Deficiency Anaemia, Inflammatory Bowel Disease, or Crohn's D Clinical Trial using ST10-021; Placebo Comparator

Iron Therapeutics - Recruiting 18 years or older.
- A Prospective, Multicentre, Randomised, Double-blind, Placebo Controlled Study With Oral ST10-021 for the Treatment of Iron Deficiency Anaemia in Subjects With Quiescent Crohn's Disease Where Oral Ferrous Preparations Have Failed or Cannot be Used (AEGIS 2).
ST10-021; Placebo Comparator

Crohn's Disease, or Ulcerative Colitis Clinical Trial using smoking of cannabis; smoking cigarettes with placebo

Meir Medical Center - Recruiting 20 years to 70 years.
- A Double Blind Placebo Controlled Study of Cannabis Smoking in Inflammatory Bowel Disease.
smoking of cannabis; smoking cigarettes with placebo

Inflammatory Bowel Disease, or Colorectal Cancer Clinical Trial

UMC Utrecht - Recruiting 18 years to 70 years.
- Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study.

Inflammatory Bowel Disease, Ulcerative Colitis, or Crohn's Diseas Clinical Trial

Children's Hospital Boston - Recruiting N/A to 18 years.
- Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease.